Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF

NCT02387229 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
1238
Enrollment
OTHER
Sponsor class

Stopped Consensus BRAIN-AF Executive Steering Committee to terminate.

Conditions

Interventions

Sponsor

Montreal Heart Institute

Collaborators